SUBLICENSE AGREEMENTSublicense Agreement • May 1st, 2013 • BG Medicine, Inc. • In vitro & in vivo diagnostic substances
Contract Type FiledMay 1st, 2013 Company IndustryThis Sublicense Agreement (hereinafter referred to as this “AGREEMENT”) effective as of 11 July 2012 (the “Effective Date”), is made and entered into by and between ACS Biomarker B.V., a corporation organized and duly existing under the laws of the Netherlands, having its office at Oxfordlaan 70, 6229 EV Maastricht, (hereinafter referred to as “ACSB”) and BG Medicine, Inc., a Delaware corporation having its registered office at 610 N. Lincoln Street, Waltham, MA 02451 (hereinafter referred to as “BGM”).
SUBLICENSE AGREEMENTSublicense Agreement • November 13th, 2012 • BG Medicine, Inc. • Services-medical laboratories
Contract Type FiledNovember 13th, 2012 Company IndustryThis Sublicense Agreement (hereinafter referred to as this “AGREEMENT”) effective as of 11 July 2012 (the “Effective Date”), is made and entered into by and between ACS Biomarker B.V., a corporation organized and duly existing under the laws of the Netherlands, having its office at Oxfordlaan 70, 6229 EV Maastricht, (hereinafter referred to as “ACSB”) and BG Medicine, Inc., a Delaware corporation having its registered office at 610 N. Lincoln Street, Waltham, MA 02451 (hereinafter referred to as “BGM”).